BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1700159)

  • 1. Re: Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate.
    McVary KT; Rademaker AW
    J Urol; 1990 Dec; 144(6):1485-6. PubMed ID: 1700159
    [No Abstract]   [Full Text] [Related]  

  • 2. Nondetectable prostate-specific antigen in moderately differentiated adenocarcinoma of prostate.
    Daugherty RL; Cos LR; Keller JW; di Sant'Agnese A
    Urology; 1992 Jun; 39(6):552-5. PubMed ID: 1377434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate specific antigen in diagnosis, staging, and follow-up of prostate cancer.
    Cooper EH
    Prostate Suppl; 1992; 4():125-8. PubMed ID: 1374175
    [No Abstract]   [Full Text] [Related]  

  • 4. Prostate-specific antigen. Improving its ability to diagnose early prostate cancer.
    Oesterling JE
    JAMA; 1992 Apr 22-29; 267(16):2236-8. PubMed ID: 1372945
    [No Abstract]   [Full Text] [Related]  

  • 5. Re: The added value of percentage of free to total prostate-specific antigen, PCA3, and a kallikrein panel to the ERSPC risk calculator for prostate cancer in prescreened men.
    Taneja SS
    J Urol; 2015 Jan; 193(1):127. PubMed ID: 25523657
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum prostate-specific antigen: the most useful tumor marker.
    Andriole GL
    J Clin Oncol; 1992 Aug; 10(8):1205-7. PubMed ID: 1378885
    [No Abstract]   [Full Text] [Related]  

  • 7. Prostate specific antigen.
    Med Lett Drugs Ther; 1992 Oct; 34(880):93-4. PubMed ID: 1381807
    [No Abstract]   [Full Text] [Related]  

  • 8. Digital rectal examination-associated alterations in serum prostate-specific antigen.
    Gillenwater JY
    Am J Clin Pathol; 1992 Apr; 97(4):466-7. PubMed ID: 1372786
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical usefulness of prostate-specific antigen and prostatic acid phosphatase in patients with prostatic cancer.
    Filella X; Molina R; Jo J; Umbert B; Bedini JL; Ballesta AM
    Tumour Biol; 1990; 11(6):289-94. PubMed ID: 1700860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate antigen. A new perception of use in serum.
    Griffiths J
    Am J Clin Pathol; 1989 Dec; 92(6):845-6. PubMed ID: 2480063
    [No Abstract]   [Full Text] [Related]  

  • 11. Diagnosis of prostate cancer: a personal view.
    Stamey TA
    J Urol; 1992 Mar; 147(3 Pt 2):830-2. PubMed ID: 1371556
    [No Abstract]   [Full Text] [Related]  

  • 12. Will emerging prostate cancer markers redeem themselves?
    Hotakainen K; Stenman UH
    Clin Chem; 2010 Aug; 56(8):1212-3. PubMed ID: 20570933
    [No Abstract]   [Full Text] [Related]  

  • 13. [Related biomarkers in the diagnosis of prostate cancer].
    Xu YM; Liu HZ
    Zhonghua Nan Ke Xue; 2015 Oct; 21(10):937-40. PubMed ID: 26665686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comments on the article "Biomarkers for prostate cancer" by Eric Schiffer.
    Marshall S
    World J Urol; 2009 Aug; 27(4):577-8. PubMed ID: 19543735
    [No Abstract]   [Full Text] [Related]  

  • 15. Value of prostate-specific antigen measurements in predicting lymph node involvement in prostatic cancer.
    Arai Y; Yoshiki T; Yamabe H; Yoshida O
    Urol Int; 1990; 45(6):356-60. PubMed ID: 1705062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of the markers PAP-PSA in the diagnosis of cancer of the prostate].
    Petrone U; Gaspari G; Marascia G; Magnocavallo N; Petrone D; Tucci C
    Minerva Urol Nefrol; 1990; 42(2):73-5. PubMed ID: 1697431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biopsy after external beam radiation therapy for adenocarcinoma of the prostate: correlation with original histological grade and current prostate specific antigen levels.
    Dugan TC; Shipley WU; Young RH; Verhey LJ; Althausen AF; Heney NM; McManus PL; Abraham EH
    J Urol; 1991 Nov; 146(5):1313-6. PubMed ID: 1719244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early prostate cancer antigen-2: a controversial prostate cancer biomarker?
    Diamandis EP
    Clin Chem; 2010 Apr; 56(4):542-4. PubMed ID: 20167690
    [No Abstract]   [Full Text] [Related]  

  • 19. Predicting and monitoring results of therapy.
    Paulson DF
    J Urol; 1992 Mar; 147(3 Pt 2):967. PubMed ID: 1371569
    [No Abstract]   [Full Text] [Related]  

  • 20. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. I. Untreated patients.
    Stamey TA; Kabalin JN
    J Urol; 1989 May; 141(5):1070-5. PubMed ID: 2468794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.